Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5463_Библиотеки_им_академика_М_И_Перельмана.pdf
238
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Fabrication Process. JOM 2016, 68 (7), 1978–1982.
Int. J. Pharm. 2021, 600, 120524.
Microporous Mesoporous Mater. 2018, 272,
24–30.
Int. J.
Pharmaceut. 2018, 544 (2), 425–432.
Eur. J. Pharm. Biopharm. 2019, 135, 94–103.
Eur. J. Pharm. Biopharm. 2015, 96, 380–387.
Polymers 2018, 10 (11), 1208.
Drug Deliv.
Transl. Res. 2022, 1–16.
Copolymers. J. Biomed. Mater. Res. 1979, 13 (3), 497–507.
Addit. Manuf. 2019, 29, 100776.
Drug Dev.
Ind. Pharm. 2016, 42 (7), 1019–1031.
Delivery Systems. ChemistrySelect. 2020, 5 (19), 5537–5551.
Expert Opin. Ther. Pat. 2020, 30
(6), 433–452.
Inserts in a Novel Biopharmaceutical Bladder Model. Int. J. Pharm. 2022, 624, 121984.
Polymers 2022, 14 (4), 763.
3D Printed Devices as Drug Delivery Systems
239
Lancet North Am. Ed.
2017, 390 (10095), 649–658.
J. Controlled Release
2000, 66 (1), 11–17.
J. Controlled
Release 2018, 269, 355–363.
NPJ Mater. Degrad. 2022, 6 (1), 68.
J. Orthop. Trauma
2017, 31, S20-S22.
Pharmaceutics 2021, 13 (4), 543.
Int. J. Pharm. 2022,
620, 121750.
Healthcare Challenges. J. Controll. Release 2021, 332, 367–389.
Procedia Manuf. 2019, 35, 1286–1296.
J. Dent. Res.
2018, 97 (1), 68–76.
Popular Component, Polyethylene Glycol and Its Alternatives. Adv. Drug. Deliv. Rev. 2022,
180, 114079.
Int.
J. Pharm. 2021, 597, 120315.
Theranostics 2020,
10 (23), 10652.
Films. Int. J. Pharm. 2019, 564, 117–123.
Pharmaceutics
2021, 13 (12), 2123.
Int. J. Pharm. 2018, 544
(1), 21–30.
240
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Release, Drug-Polymer Miscibility and Printability. J. Pharm. Sci. 2018, 107 (1), 390–401.
Small 2018,
14 (49), 1803266.
Int. J. Pharm. 2019, 561,
124–134.
Prolonged Drug Delivery Using 3D Printing. Pharmaceutics 2020, 12 (2), 105.
Bone Regeneration. Chem. Eng. J. 2022, 427, 130961.
Polymers 2018, 10 (11), 1290.
Medicine. Adv. Mater. 2015, 27 (47), 7847–7853.
Drug Deliv. Transl. Res. 2022, 1–12.
Int. J. Pharm. 2021, 593, 120147.
Int.
J. Pharm. 2021, 594, 120118.
and Bioprinting. Green Chem. 2022, 24 (1), 62–101.
Polymer. Polym. Bull. 2022, 1–35.
Pharmaceutics 2022, 14 (8), 1575.
3D Printing. Polymers 2019, 12 (1), 27.
Medicine.
J. Controlled Release 2020, 322, 42–52.
3D Printed Devices as Drug Delivery Systems
241
Int. J. Pharm. 2021, 598, 120370.
Biomed. Pharmacother. 2022, 148, 112785.
Dispersions. Pharmaceutics 2021, 13 (8), 1149.
Eur. J. Pharm. Biopharm. 2021, 163, 141–156.
®
Expert
Opin. Drug Deliv. 2013, 10 (1), 131–149.
Using a Quality by Design (QBD) Approach. Int. J. Pharm. 2021, 599, 120402.
Shoot Approach. Int. J. Pharm. 2018, 549 (1–2), 283–292.
Osteomyelitis. Pharmaceutics 2019, 11 (2), 94.
Int. J. Pharm.
2020, 581, 119298.
Eur. J.
Pharm. Sci. 2021, 158, 105619.
Mater. Sci. Eng. C 2018, 87, 78–89.
Fused Deposition Modeling 3D Printing to Develop Hydroxypropyl Cellulose Based
Carbohydr. Polym. 2020, 246, 116519.
System. Biomed. Pharmacother. 2019, 109, 1249–1258.
Strategies and Applications. Macromol. Rapid Commun.
2022, 43 (8), 2200037.
Materials
Science and Engineering: C 2018, 84, 44–51.
242
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Int. J. Pharm. 2020,
580, 119219.
Acta Biomater.
2019, 88, 301–313.
Fabricated via Selective Laser Sintering. Biomaterials 2005, 26 (23), 4817–4827.
Pharmaceutics 2022, 14 (5), 931.
Vivo. Cell Prolif. 2020, 53 (1), e12725.
Polymers 2019, 11 (12),
1924.
Pharmaceutics 2020, 12 (11), 1077.
Properties and Laser Beam Material Interaction. Phys. Procedia 2016, 83, 991–1002.
Stem Cell Rev. Rep. 2019, 15 (5), 664–679.
Sci. Rep. 2019, 9 (1), 1–8.
Adv. Funct.
Mater. 2022, 2202470.
Int. J. Pharm. 2021, 605, 120815.
Printing. Int. J. Biol. Macromol. 2019, 121, 309–316.
Engineering 2018, 4 (5), 729–7
42.
Release. Int. J. Pharm. 2018, 552 (1–2), 91–98.
Biomaterials 2020, 230, 119618.
3D Printed Devices as Drug Delivery Systems
243
Materials 2022,
214, 110394.
J. Controlled Release 2016, 238, 231–241.
Printing. Int. J. Pharm. 2021, 604, 120626.
Deposition Modelling. Int. J. Pharm. 2022, 625, 122140.
Pharmaceutics 2021, 13 (10), 1613.
Int. J.
Pharm. 2020, 590, 119945.
Macromolecule Delivery. Research 2022, 2022.
Biofabrication
2020, 12 (2), 025026.
Sci. Rep. 2019, 9 (1), 1–13.
Advances in Pharmaceutical T echnology for Drug Delivery Systems (PTDDS), Volume 2: Recent Progress
in Biomedical Applications. Sougata Jana (Ed.)
© 2025 Apple Academic Press, Inc. Co-published with CRC Press (Taylor & Francis)
Nanofiber Technology in Biomedical
Applications
SANDIP KARMAKAR
1
, SREEJAN MANNA
2
, and SOUGATA JANA
3
1
2
3
CHAPTER 8
ABSTRACT
to their various applications in the pharmaceutical and biomedical sectors.
-
Among them, the electrospinning technique is very much popular due to its
-
246
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
application.
8.1 INTRODUCTION
application in pharmaceutical, biomedical, and energy applications (Morie
-
-
bers because they are biodegradable materials and they decompose inside the
Nanofiber Technology in Biomedical Applications
247
-
polyvinyl pyrrolidone (PVP), polyurethane (PU), polyvinyl alcohol (PVA),
polyglycolic acid (PGA), polylactic acid (PLA), polycaprolactone, polyvinyl
chloride (PVC), poly-l-lactide, polycarbonate, polyethylene oxide, polyvinyl
et al., 2017).
molecule, they have the ability to deliver the encapsulated drug substance
(NSAIDs), vitamins, natural products, antibiotics and antibacterial agents,
dressings (Bhattarai et al., 2018).
8.2 VARIOUS PARAMETERS AFFECTING THE PROPERTIES OF
NANOFIBERS
-